The International Council for Harmonisation (ICH) writes the shared standards; each region builds them into its own rules (in the US, 21 CFR 314.80 and 312.32; in the EU, the Directive, its implementing regulation and the GVP modules). The ones a drug safety associate uses:
- E2A: clinical safety data management. Definitions (adverse event, adverse drug reaction, serious, unexpected) and the standards for expedited reporting in clinical trials.
- E2B(R3): the electronic ICSR: its data elements and the format for sending cases.
- E2C(R2): the periodic benefit-risk evaluation report (PBRER).
- E2D(R1): post-approval safety data: sources, validity, day 0, follow-up, narratives, duplicates.
- E2E: pharmacovigilance planning. A safety specification summarises the important identified risks, the important potential risks and the important missing information; a pharmacovigilance plan sets out how they will be studied.
- M1: MedDRA, the medical dictionary that E2B(R3) uses for reactions, indications and history.